The cardiac valve market size has grown rapidly in recent years. It will grow from $12.41 billion in 2025 to $14.24 billion in 2026 at a compound annual growth rate (CAGR) of 14.8%. The growth in the historic period can be attributed to rising incidence of valvular heart diseases, expansion of cardiac surgery programs, growing use of mechanical heart valves, advancements in surgical valve techniques, increasing availability of cardiac care facilities.
The cardiac valve market size is expected to see rapid growth in the next few years. It will grow to $24.02 billion in 2030 at a compound annual growth rate (CAGR) of 14%. The growth in the forecast period can be attributed to increasing demand for transcatheter interventions, rising focus on elderly cardiac care, expansion of hybrid cardiac procedures, growing investments in next-generation valve technologies, increasing adoption of patient-specific valve solutions. Major trends in the forecast period include increasing adoption of transcatheter valve procedures, rising demand for bioprosthetic heart valves, growing preference for minimally invasive valve replacement, expansion of advanced valve repair techniques, enhanced focus on valve durability and performance.
The increasing prevalence of cardiovascular diseases is poised to drive the growth of the cardiac valve market. Factors such as smoking, obesity, lack of physical activity, and other cardiovascular stressors contribute to a gradual rise in cardiovascular diseases. Coronary artery disease, characterized by the build-up of fatty plaques in arteries, is a common cause. This surge in heart-related ailments has heightened the demand for cardiac valves to address heart valve issues. As of September 2023, data from the World Health Organization indicates that cardiovascular diseases account for a substantial portion, approximately 74%, of global deaths related to non-communicable diseases (NCDs) or chronic conditions.
Major players in the cardiac valve market are advancing transfemoral transcatheter mitral valve replacement (TMVR) systems to address the growing demand for minimally invasive therapies in patients with mitral regurgitation. TMVR systems use collapsible frames and biologic valve leaflets delivered via catheter through the femoral vein, avoiding open-heart surgery and reducing recovery time and procedural risk. In April 2025, Edwards Lifesciences received CE Mark approval for the SAPIEN M3 System, featuring a docking mechanism for stable leaflet capture and precise bioprosthetic valve deployment, enabling repositioning and retrieval to improve safety and expand treatment to patients ineligible for surgery or edge-to-edge repair.
In July 2024, Edwards Lifesciences acquired JenaValve Technology for an upfront USD 500 million, with up to USD 445 million in contingent payments, to expand its cardiac valve portfolio and strengthen its position in aortic regurgitation treatment. The acquisition allows Edwards to integrate JenaValve’s Trilogy transcatheter heart valve system, enhancing its offerings in minimally invasive structural heart therapies. JenaValve’s expertise in transcatheter valve technologies supports Edwards’ strategic growth in high-risk patient populations, reflecting a broader trend in the cardiac device market toward acquisitions that advance portfolio diversification and innovative solutions for complex valve disease.
Major companies operating in the cardiac valve market are Abbott Laboratories, Edwards Lifesciences Corporation, Medtronic plc, Artivion Inc., Meril Life Sciences Pvt Ltd, Lepu Medical Technology Co Ltd, TTK Healthcare Limited, Braile Biomédica, JenaValve Technology Inc., Xeltis AG, Colibri Heart Valve LLC, On-X Life Technologies Inc., Thubrikar Aortic Valve Inc., LifeNet Health Inc., Auto Tissue Berlin GmbH, CryoLife Inc., LivaNova PLC, Foldax Inc., Micro Interventional Devices Inc., InnovHeart Srl.
North America was the largest region in the cardiac valve market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac valve market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cardiac valve market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the cardiac valve market by increasing costs of imported biomaterials, precision metal components, manufacturing equipment, and sterilization systems used in mechanical and tissue valves. Hospitals and specialty cardiac centers in North America and Europe are most affected due to reliance on imported valve products, while Asia-Pacific faces higher production input costs. These tariffs are raising procedure expenses and procurement budgets. However, they are also supporting domestic valve manufacturing, regional innovation, and localized production of advanced cardiac valve solutions.
The cardiac valve market research report is one of a series of new reports that provides cardiac valve market statistics, including cardiac valve industry global market size, regional shares, competitors with a cardiac valve market share, detailed cardiac valve market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac valve industry. This cardiac valve market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Cardiac valves are artificial devices designed to regulate the flow of blood within the heart, ensuring unidirectional blood movement from the heart to other parts of the body. These implantable devices play a crucial role in replacing damaged valves that may have ceased functioning due to various diseases. The primary objective of cardiac valves is to maintain the proper flow of blood through the heart and into the major blood vessels connected to it.
The primary types of cardiac valves include tissue valves, transcatheter valves, mechanical valves, and other variations. Tissue heart valves, utilized in open-heart or minimally invasive surgeries, aim to prevent blood clot formation inside the vessels. These valves are crafted from durable and flexible animal tissue obtained from donors and are employed in cardiac valve repair and replacement procedures. Various positions in the heart, such as the aortic valve and mitral valve, necessitate the repair or replacement of cardiac valves. End-users of cardiac valves include hospitals, clinics, specialty centers, cardiac research institutes, and other healthcare facilities.
The cardiac valve market consists of sales of tricuspid valves and pulmonary valves. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The cardiac valve market size is expected to see rapid growth in the next few years. It will grow to $24.02 billion in 2030 at a compound annual growth rate (CAGR) of 14%. The growth in the forecast period can be attributed to increasing demand for transcatheter interventions, rising focus on elderly cardiac care, expansion of hybrid cardiac procedures, growing investments in next-generation valve technologies, increasing adoption of patient-specific valve solutions. Major trends in the forecast period include increasing adoption of transcatheter valve procedures, rising demand for bioprosthetic heart valves, growing preference for minimally invasive valve replacement, expansion of advanced valve repair techniques, enhanced focus on valve durability and performance.
The increasing prevalence of cardiovascular diseases is poised to drive the growth of the cardiac valve market. Factors such as smoking, obesity, lack of physical activity, and other cardiovascular stressors contribute to a gradual rise in cardiovascular diseases. Coronary artery disease, characterized by the build-up of fatty plaques in arteries, is a common cause. This surge in heart-related ailments has heightened the demand for cardiac valves to address heart valve issues. As of September 2023, data from the World Health Organization indicates that cardiovascular diseases account for a substantial portion, approximately 74%, of global deaths related to non-communicable diseases (NCDs) or chronic conditions.
Major players in the cardiac valve market are advancing transfemoral transcatheter mitral valve replacement (TMVR) systems to address the growing demand for minimally invasive therapies in patients with mitral regurgitation. TMVR systems use collapsible frames and biologic valve leaflets delivered via catheter through the femoral vein, avoiding open-heart surgery and reducing recovery time and procedural risk. In April 2025, Edwards Lifesciences received CE Mark approval for the SAPIEN M3 System, featuring a docking mechanism for stable leaflet capture and precise bioprosthetic valve deployment, enabling repositioning and retrieval to improve safety and expand treatment to patients ineligible for surgery or edge-to-edge repair.
In July 2024, Edwards Lifesciences acquired JenaValve Technology for an upfront USD 500 million, with up to USD 445 million in contingent payments, to expand its cardiac valve portfolio and strengthen its position in aortic regurgitation treatment. The acquisition allows Edwards to integrate JenaValve’s Trilogy transcatheter heart valve system, enhancing its offerings in minimally invasive structural heart therapies. JenaValve’s expertise in transcatheter valve technologies supports Edwards’ strategic growth in high-risk patient populations, reflecting a broader trend in the cardiac device market toward acquisitions that advance portfolio diversification and innovative solutions for complex valve disease.
Major companies operating in the cardiac valve market are Abbott Laboratories, Edwards Lifesciences Corporation, Medtronic plc, Artivion Inc., Meril Life Sciences Pvt Ltd, Lepu Medical Technology Co Ltd, TTK Healthcare Limited, Braile Biomédica, JenaValve Technology Inc., Xeltis AG, Colibri Heart Valve LLC, On-X Life Technologies Inc., Thubrikar Aortic Valve Inc., LifeNet Health Inc., Auto Tissue Berlin GmbH, CryoLife Inc., LivaNova PLC, Foldax Inc., Micro Interventional Devices Inc., InnovHeart Srl.
North America was the largest region in the cardiac valve market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac valve market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cardiac valve market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the cardiac valve market by increasing costs of imported biomaterials, precision metal components, manufacturing equipment, and sterilization systems used in mechanical and tissue valves. Hospitals and specialty cardiac centers in North America and Europe are most affected due to reliance on imported valve products, while Asia-Pacific faces higher production input costs. These tariffs are raising procedure expenses and procurement budgets. However, they are also supporting domestic valve manufacturing, regional innovation, and localized production of advanced cardiac valve solutions.
The cardiac valve market research report is one of a series of new reports that provides cardiac valve market statistics, including cardiac valve industry global market size, regional shares, competitors with a cardiac valve market share, detailed cardiac valve market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac valve industry. This cardiac valve market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Cardiac valves are artificial devices designed to regulate the flow of blood within the heart, ensuring unidirectional blood movement from the heart to other parts of the body. These implantable devices play a crucial role in replacing damaged valves that may have ceased functioning due to various diseases. The primary objective of cardiac valves is to maintain the proper flow of blood through the heart and into the major blood vessels connected to it.
The primary types of cardiac valves include tissue valves, transcatheter valves, mechanical valves, and other variations. Tissue heart valves, utilized in open-heart or minimally invasive surgeries, aim to prevent blood clot formation inside the vessels. These valves are crafted from durable and flexible animal tissue obtained from donors and are employed in cardiac valve repair and replacement procedures. Various positions in the heart, such as the aortic valve and mitral valve, necessitate the repair or replacement of cardiac valves. End-users of cardiac valves include hospitals, clinics, specialty centers, cardiac research institutes, and other healthcare facilities.
The cardiac valve market consists of sales of tricuspid valves and pulmonary valves. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Cardiac Valve Market Characteristics
3. Cardiac Valve Market Supply Chain Analysis
4. Global Cardiac Valve Market Trends and Strategies
5. Cardiac Valve Market Analysis of End Use Industries
7. Global Cardiac Valve Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Cardiac Valve Total Addressable Market (TAM) Analysis for the Market
9. Cardiac Valve Market Segmentation
10. Cardiac Valve Market Regional and Country Analysis
11. Asia-Pacific Cardiac Valve Market
12. China Cardiac Valve Market
13. India Cardiac Valve Market
14. Japan Cardiac Valve Market
15. Australia Cardiac Valve Market
16. Indonesia Cardiac Valve Market
17. South Korea Cardiac Valve Market
18. Taiwan Cardiac Valve Market
19. South East Asia Cardiac Valve Market
20. Western Europe Cardiac Valve Market
21. UK Cardiac Valve Market
22. Germany Cardiac Valve Market
23. France Cardiac Valve Market
24. Italy Cardiac Valve Market
25. Spain Cardiac Valve Market
26. Eastern Europe Cardiac Valve Market
27. Russia Cardiac Valve Market
28. North America Cardiac Valve Market
29. USA Cardiac Valve Market
30. Canada Cardiac Valve Market
31. South America Cardiac Valve Market
32. Brazil Cardiac Valve Market
33. Middle East Cardiac Valve Market
34. Africa Cardiac Valve Market
36. Cardiac Valve Market Competitive Landscape and Company Profiles
37. Cardiac Valve Market Other Major and Innovative Companies
40. Cardiac Valve Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Cardiac Valve Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses cardiac valve market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for cardiac valve? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiac valve market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Tissue Heart Valves; Transcatheter Heart Valves; Mechanical Heart Valves2) By Position: Aortic Valve; Mitral Valve; Other Positions
3) By Treatment: Cardiac Valve Repair; Cardiac Valve Replacement
4) By End-Users: Hospital And Clinics; Specialty Centers; Cardiac Research Institute; Other End Users
Subsegments:
1) By Tissue Heart Valves: Bioprosthetic Valves (e.g., porcine, bovine); Homograft Valves2) By Transcatheter Heart Valves: Transcatheter Aortic Valve Replacement (TAVR / TAVI) Valves; Transcatheter Mitral Valve Replacement (TMVR) Valves
3) By Mechanical Heart Valves: Tilting Disc Valves; Bileaflet Valves; Caged Ball Valves
Companies Mentioned: Abbott Laboratories; Edwards Lifesciences Corporation; Medtronic plc; Artivion Inc.; Meril Life Sciences Pvt Ltd; Lepu Medical Technology Co Ltd; TTK Healthcare Limited; Braile Biomédica; JenaValve Technology Inc.; Xeltis AG; Colibri Heart Valve LLC; On-X Life Technologies Inc.; Thubrikar Aortic Valve Inc.; LifeNet Health Inc.; Auto Tissue Berlin GmbH; CryoLife Inc.; LivaNova PLC; Foldax Inc.; Micro Interventional Devices Inc.; InnovHeart Srl
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Cardiac Valve market report include:- Abbott Laboratories
- Edwards Lifesciences Corporation
- Medtronic plc
- Artivion Inc.
- Meril Life Sciences Pvt Ltd
- Lepu Medical Technology Co Ltd
- TTK Healthcare Limited
- Braile Biomédica
- JenaValve Technology Inc.
- Xeltis AG
- Colibri Heart Valve LLC
- On-X Life Technologies Inc.
- Thubrikar Aortic Valve Inc.
- LifeNet Health Inc.
- Auto Tissue Berlin GmbH
- CryoLife Inc.
- LivaNova PLC
- Foldax Inc.
- Micro Interventional Devices Inc.
- InnovHeart Srl
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 14.24 Billion |
| Forecasted Market Value ( USD | $ 24.02 Billion |
| Compound Annual Growth Rate | 14.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
